Physician profile
Stephanie Hendricks
NPI 1891464277
$497.44
in general payments reported to CMS, 2019-2025
12 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $158 · 2024: $56.89 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $97.03 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $85.00 | 2022 | |
| Pfizer INC. | $80.66 | 2023-2025 | |
| Philips North America LLC | $48.43 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Lilly USA, LLC | $42.23 | 2024-2025 | Mounjaro, Zepbound, Reyvow |
| Organon LLC | $35.66 | 2023 | Nexplanon |
| Phadia US INC. | $23.41 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.33 | 2025 | |
| Sumitomo Pharma America, INC. | $20.19 | 2023 | Myfembree |
| Otsuka America Pharmaceutical, INC. | $14.36 | 2023 | Rexulti |
| Abbvie INC. | $14.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.